| Pharmaceutical active ingredients: |
| Pindolol |
| Available forms, composition and doses of Carvisken: |
| N / A |
| Carvisken medical category: |
| Human:Beta-adrenergic blocking agentsHMG-COA reductase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07AA03 - Pindolol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cartric | Rescinnamine | Unidentified Pharmaceutical Company |
| Carvacron | Trichlormethiazide | Unidentified Pharmaceutical Company |
| Carvanil | Isosorbide Dinitrate | Unidentified Pharmaceutical Company |
| Carvasept | 5-Chlorocarvacrol | Unidentified Pharmaceutical Company |
| Carvene | Limonene | Unidentified Pharmaceutical Company |
| Carxamin | Tranexamic Acid | Unidentified Pharmaceutical Company |
| Caryolysin | Mechlorethamine | Unidentified Pharmaceutical Company |
| Carzonal | Fluorouracil | Unidentified Pharmaceutical Company |
| Casakol | Casanthranol | Unidentified Pharmaceutical Company |
| Cassel Green | Manganese Oxide | Unidentified Pharmaceutical Company |